Background
==========

*Coccidioides immitis* and *posadasii* are dimorphic fungi endemic to the Sonoran life zone. Their endemicity extends from Latin America to central California \[[@b1-amjcaserep-21-e924179]\]. Both organisms produce an identical clinical illness, predominantly acute pneumonia, but may cause chronic pulmonary disease and extrapulmonary complications. Dissemination may evolve and result in fatal central nervous system infection \[[@b2-amjcaserep-21-e924179]\]. Some areas within California and Arizona are hyperendemic. Because of variability in symptom severity, many cases are not diagnosed and are thus unreported. Venous thromboembolism (VTE) has not been reported as a recognized complication of coccidioidomycosis. Indeed, we had not recognized a single VTE episode in any of the cases of *Coccidioides* infection treated by us or our colleagues over the past few decades. It was therefore remarkable to encounter, within 1 year, pulmonary embolism occurring in 4 patients with pulmonary coccidioidomycosis and in another patient with coccidioidomycosis pneumonia and cutaneous and meningeal infection.

Case Reports
============

A 35-year-old man was well until fever and dyspnea occurred. Two weeks later he was seen by a physician and treated with an oral antibiotic. Symptoms persisted, and he was admitted to a neighboring hospital. A computed tomography (CT) scan of his chest revealed right lower and right upper lobe infiltrates with ipsilateral hilar adenopathy. Intravenous antibiotics were administered, and he was discharged after several days. Symptoms of fever, night sweats, pleuritic chest pain, and dyspnea worsened, and he was admitted to our hospital.

Physical examination disclosed an obese Latino male, awake and alert, in mild respiratory distress. Respiratory rate was 19 breaths per minute and oxygen saturation was 94% on room air. Blood pressure was normal. The temperature was 100.8°F (38.2°C). Breath sounds were diminished over the right hemi thorax, with diffuse crackles. Examination of the heart, abdomen, extremities, and neurological system was unremarkable. He had no adenopathy or rash.

Laboratory studies showed a white blood count of 13 600/μL (normal: 4800--10 800/μL). Hemoglobin was 14.3 gm/dL (normal: 14--18 gm/dL) and the platelet count was 485 000/μL (normal 130 000--400 000/μL). A differential count showed 73% neutrophils, 13% lymphocytes, 9.6% monocytes, 2.8% eosinophils, and 1.3% basophils. Erythrocyte sedimentation rate was 80 mm/hr (normal: 0--15 mm/hr). C reactive protein was 9.74 (normal: 0.05--0.3 mg/dL). Serologic assay for human immuno-deficiency virus was negative, as was a QuantiFERON-TB Gold assay for tuberculosis. PCR assay for influenza A and B was negative. Urinary Legionella antigen was negative by enzyme immunoassay (EIA). Serologic assay for Mycoplasma antibodies was also negative.

Vancomycin and Ceftriaxone were administered but were discontinued after 24 hours once it was determined by review of records that he had received 6 different antibiotics over the preceding 4 weeks. Fluconazole 800 mg was given orally, as coccidioidomycosis was considered the most likely diagnosis. Enoxaparin 40 mg was administered daily by subcutaneous injection during the hospitalization. It was necessary to discontinue the anticoagulant prophylaxis from time to time because of invasive procedures, in which case intermittent pneumatic compression stockings were utilized.

Repeat chest CT showed right upper lobe, right middle lobe, left mid-lung infiltrates, and multiple cavitary lesions. Blood and sputum cultures remained negative. Fever persisted up to 103°F (39.4°C). A bronchoscopy was performed on the sixth hospital day. On the eighth hospital day, fever and increasing oxygen requirement prompted another chest CT, which showed extensive emboli in the left lower lobe pulmonary artery ([Figure 1](#f1-amjcaserep-21-e924179){ref-type="fig"}). Mediastinal adenopathy was more prominent; pulmonary infiltrates and cavities were unchanged. A venous ultrasound showed bilateral posterior tibial and left peroneal vein thrombi. Factor V Leiden and prothrombin gene mutations by PCR assay were negative. He was placed on rivaroxaban 20 mg. Immunodiffusion assay for coccidioidomycosis returned as positive, and the complement fixation assay was reported at 1: 32. Bronchial alveolar lavage fluid grew *C. immitis*. Smears for mycobacteria and a DNA probe for *M. tuberculosis* were negative. Cerebrospinal fluid was negative for antibody to coccidioidomycosis. Liposomal amphotericin B 450 mg daily was administered, and intravenous fluconazole 1000 mg was continued with subsequent improvement over the next 14 days. He was discharged on oral fluconazole 800 mg daily.

A summary of all 5 cases is shown in [Table 1](#t1-amjcaserep-21-e924179){ref-type="table"}. All patients were treated with rivaroxaban because of lesser drug--drug interactions with fluconazole.

Discussion
==========

Infection is associated with a thrombophilic state through a variety of mechanisms, resulting in activation of the coagulation cascade and decreased fibrinolysis \[[@b3-amjcaserep-21-e924179]\]. Such activation can occur regardless of the infecting organism \[[@b4-amjcaserep-21-e924179]\] or its chronicity \[[@b5-amjcaserep-21-e924179]\]. Despite the relatively large number of cases diagnosed in our area \[[@b6-amjcaserep-21-e924179]\], we had not, in our collective memory, seen VTE complicate the course of coccidioidomycosis, even in those with severe disease and prolonged hospitalization. We searched the medical literature using medical subject headings (MeSH) generated by the National Library of Medicine for MEDLINE/PubMed alone and in combination, without finding any report of pulmonary emboli associated with a diagnosis of coccidioidomycosis. Discussion with other clinicians with extensive experience diagnosing and treating coccidioidomycosis in highly endemic areas failed to yield similar cases. We queried other regional expert clinicians with the thought that they may have also treated such cases but did not report them. We encountered 3 cases of VTE in ambulatory patients who initially presented with a clinical syndrome consistent with pneumonia. Dyspnea prompted an emergency room visit, and in each case both pulmonary infiltrates and pulmonary embolism were defined at that initial visit. Two of these patients were diagnosed with pneumonia and VTE at other hospitals and were later referred for ongoing treatment. The fourth patient presented with VTE during a clinic visit 1 week after hospital discharge following treatment for coccidioidomycosis meningitis. The fifth patient, described in the case report, developed pulmonary emboli while hospitalized for pneumonia. Review of the records and images of each patient confirmed the presence of multiple emboli ([Figure 2](#f2-amjcaserep-21-e924179){ref-type="fig"}), and each was prescribed anticoagulant therapy with rivaroxaban \[[@b7-amjcaserep-21-e924179]\].

Conclusions
===========

One could speculate that discovery of pulmonary emboli in these cases reflects the now common practice of ordering a computerized tomography angiogram (CTA) when encountering patients with respiratory complaints, and the relative ease with which such a study can be performed and interpreted \[[@b8-amjcaserep-21-e924179]\]. CTA has been available in our local hospitals for many years, and each of the cases reviewed were encountered only in the past year (2019). Risk factors for VTE, such as immobility, can also be seen in significant pulmonary infections, such as those caused by coccidiomycosis. Yet, with the exception of 2 patients, immobility at home or in hospital was not a feature of their illness. Three of the patients with pneumonia, though fatigued and feeling ill, remained ambulatory throughout their pre-hospital course. Another possibility might be environmental changes. The region, Ventura County, where all 5 patients were likely infected experienced major fires (155 193 hectares or 591.5 square miles burned) during the preceding 2 years, followed by rainfall that ended a 6-year drought. These environmental changes may have favored *C. immitis* organisms that had undergone antigenic drift \[[@b9-amjcaserep-21-e924179]\], and the fungal infection elicited an immune response that reacted with phospholipids or β-2 glycoproteins, thereby lowering the threshold for thrombus formation \[[@b10-amjcaserep-21-e924179]\]. Speculation aside, we have no evidence that would illuminate the cause of VTE in these patients. We report these cases with the intent of making those caring for patients with coccidioidomycosis, or those interested in the organism and host response to it, aware of these events. By highlighting this relationship, we hope others will look closely at similar cases and help to elucidate the cause of this association.
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###### 

Tabular summary of 5 cases of coccidioidomycosis with pulmonary emboli.

  **Case**   **Age**   **Sex**   **Ethnicity**   **Location of infection**                 **Complement fixation titer at diagnosis**   **Cocci treatment**   **Pulmonary emboli (PE) location**     **VTE treatment**   **VTE risk factors**
  ---------- --------- --------- --------------- ----------------------------------------- -------------------------------------------- --------------------- -------------------------------------- ------------------- ---------------------------------------------------------------------
  1          37        F         Latino          Pneumonia (LLL)                           1: 16                                        Anti-fungal           Bilateral lower lobe and RML of lung   DOAC                Cardiolipin antibodies positive; obesity; travel prior to PE
  2          63        M         Latino          Pneumonia (LLL)                           1: 32                                        None                  Saddle Emboli                          DOAC                Transient positive anticardiolipin antibodies; obesity; splenectomy
  3          42        F         Latino          Pneumonia (RUL)                           1: 2                                         Anti-fungal           RLL of lung                            DOAC                Negative hypercoagulable evaluation
  4          45        M         Latino          CNS (basilar cisterns), pneumonia, skin   1: 64                                        Anti-fungal           LLL, RLL, RML, RUL of lung             DOAC                Recent hospitalization (2 weeks after cocci diagnosis)
  5          35        M         Latino          Pneumonia (RUL, RML, RLL)                 1: 32                                        Anti-fungal           LLL of lung                            DOAC                Tibial and left peroneal veins DVT; obesity

Cocci -- Coccidioidomycosis; VTE -- venous thromboembolism; LLL -- left lower lobe; DOAC -- direct acting oral anticoagulant; RUL -- right upper lobe; RLL -- right lower lobe; CNS -- central nervous system; RML -- right middle lobe; DVT -- deep vein thrombosis.
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